Eagle Pharmaceuticals, Inc.
FORMULATIONS OF BENDAMUSTINE

Last updated:

Abstract:

Methods of treatment using bendamustine formulations designed for small volume intravenous administration are disclosed. The methods conveniently allow shorter administration time without the active ingredient coming out of solution as compared to presently available formulations.

Status:
Application
Type:

Utility

Filling date:

10 May 2022

Issue date:

25 Aug 2022